Pharma's kryptonite

Ellul, Ian C.

Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/13826

Full metadata record

DC Field	Value	Language
dc.contributor.author	Ellul, Ian C.	-
dc.date.accessioned	2016-11-10T10:53:50Z	-
dc.date.available	2016-11-10T10:53:50Z	-
dc.date.issued	2014	-
dc.identifier.citation	Ellul, Ian, C. (2014). Pharma's kryptonite. The Synapse, 13(1), 5	en_GB
dc.identifier.uri	https://www.um.edu.mt/library/oar//handle/123456789/13826	-
dc.description.abstract	Editorial regarding the pharmaceutical industry. 2014 will herald existing and new challenges for the pharmaceutical industry. Diminishing pipelines, increasing development costs, generic competition... pharmaceutical companies are under constant pressure to innovate and collaborate if they want to survive. As a point of fact, over 700 biotechnology and pharma takeovers have occurred in the past four years	en_GB
dc.language.iso	en	en_GB
dc.publisher	Medical Portals Ltd.	en_GB
dc.rights	info:eu-repo/semantics/openAccess	en_GB
dc.subject	Pharmaceutical industry	en_GB
dc.title	Pharma's kryptonite	en_GB
dc.title.alternative	Editorial [The Synapse, 13(1)]	en_GB
dc.type	editorial	en_GB
dc.rights.holder	The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.	en_GB
dc.description.reviewed	peer-reviewed	en_GB
Appears in Collections:	The Synapse, Volume 13, Issue 1 The Synapse, Volume 13, Issue 1

Files in This Item:

File	Description	Size	Format
Pharma's kryptonite - editorial.pdf		154.3 kB	Adobe PDF	View/Open

Show simple item record Statistics